Pediatric Oncology

NCI Standard risk B-cell Acute Lymphoblastic Leukemia – Ten year outcome from India. Where are we heading towards?
Profile of neuroblastoma – experience from a tertiary paediatric oncology centre from a developing country
Belumosudil is effective in Pediatric Patients with chronic Graft-versus-Host disease after failed Ruxolitinib treatment
B-cell precursor Acute Lymphoblastic Leukemia with high hyperdiploidy who have detectable residual disease at the end of induction can be salvaged by treatment escalation
Treatment outcomes and late effects in Retinoblastoma survivors: Importance of survivor clinics
Bacterial infections and paediatric cancer: Change in trends of pathogens from an Indian Centre
Novel therapies in pediatric cancer care: A retrospective study from Armenia
Risk Factors for Relapse in Children with Hodgkin Lymphoma treated with Chemotherapy alone Protocols
Pediatric High Risk Neuroblastoma Treated with Autologous Stem Cell Transplant – Experience from a Tertiary Cancer Centre in India
KDM6A: An Emerging Biomarker for Prediction of Treatment Response and Relapse in Pediatric Acute Myeloid Leukemia
Pulmonary Function Tests in Survivors of Pediatric Hodgkin Lymphoma: A Prospective Cohort Study
Confirmed COVID-19 Impact on Pediatric Cancer Patients: Prevalence and Outcomes Report from a Tertiary Referral Hospital in Indonesia